Inogen (INGN)
(Delayed Data from NSDQ)
$8.83 USD
-0.12 (-1.34%)
Updated May 17, 2024 04:00 PM ET
After-Market: $8.80 -0.03 (-0.34%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth C Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
INGN 8.83 -0.12(-1.34%)
Will INGN be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for INGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for INGN
Inogen (INGN) Q1 Earnings Top Estimates, Revenues Up Y/Y
Here's What Key Metrics Tell Us About Inogen (INGN) Q1 Earnings
INGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Will These 5 Medical Device Stocks Beat This Earnings Season?
KORU Medical Systems Inc. (KRMD) Reports Q1 Loss, Tops Revenue Estimates
Inogen (INGN) Up 26.6% Since Last Earnings Report: Can It Continue?
Other News for INGN
Inogen Announces Executive Leadership Restructuring
Stifel Nicolaus Reaffirms Their Hold Rating on Inogen (INGN)
Analysts Offer Insights on Healthcare Companies: Inogen (INGN), Arvinas Holding Company (ARVN) and uniQure (QURE)
Needham Sticks to Their Hold Rating for Inogen (INGN)
Inogen Inc (INGN) Q1 2024 Earnings Call Transcript Highlights: Navigating Market Dynamics with ...